We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IART market cap is 2.27B. The company's latest EPS is USD 0.8660 and P/E is 33.46.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 385.19M | 398.02M | 380.85M | 381.27M | 382.42M |
Operating Income | 65.05M | 67.84M | 36.38M | 12.5M | 26.59M |
Net Income | 49.92M | 52.95M | 24.23M | 4.18M | 19.5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.52B | 1.37B | 1.54B | 1.56B | 1.54B |
Operating Income | 93.76M | 151.37M | 197.23M | 238.92M | 111.53M |
Net Income | 50.2M | 133.89M | 169.08M | 180.55M | 67.74M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.81B | 3.89B | 3.74B | 3.78B | 3.74B |
Total Liabilities | 2.08B | 2.09B | 2.07B | 2.09B | 2.16B |
Total Equity | 1.72B | 1.8B | 1.67B | 1.68B | 1.58B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.3B | 3.62B | 3.78B | 3.89B | 3.78B |
Total Liabilities | 1.89B | 2.1B | 2.1B | 2.09B | 2.19B |
Total Equity | 1.42B | 1.51B | 1.68B | 1.8B | 1.59B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 179.14M | 264.47M | 26.16M | 54.44M | 81.21M |
Investing | -3.76M | -58.58M | -13.7M | -29.25M | -36.95M |
Financing | -154.25M | -251.95M | -162.68M | -173.38M | -223.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 231.43M | 203.83M | 312.43M | 264.47M | 139.96M |
Investing | -162.67M | -68.07M | -161.44M | -58.58M | -94.18M |
Financing | -8.77M | 121.63M | -98.23M | -251.95M | -229.93M |
Market Cap | 2.27B |
Price to Earnings Ratio | 33.46 |
Price to Sales Ratio | 1.47 |
Price to Cash Ratio | 8.2 |
Price to Book Ratio | 1.43 |
Dividend Yield | - |
Shares Outstanding | 78.22M |
Average Volume (1 week) | 1.28M |
Average Volume (1 Month) | 826.44k |
52 Week Change | -50.39% |
52 Week High | 59.10 |
52 Week Low | 27.8501 |
Spread (Intraday) | 0.59 (2.03%) |
Company Name | Integra LifeSciences Holdings Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.integralife.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions